Welcome
Welcome to the FIIND Lab (Facilitating Individualized Interventions in Psychiatry and Neurodevelopment) led by Dr. Danielle Baribeau
Please come back for research information from Dr. Danielle Baribeau’s lab.
Meet the staff and students
Scientist
Dr. Danielle Baribeau is a child and adolescent psychiatrist with a clinical focus in autism, neurogenetic disorders, and psychopharmacology. She completed her PhD in clinical epidemiology and health-care research at the University of Toronto (U of T) in 2022, which focused on understanding anxiety in autism. She completed her clinical residency training in adult psychiatry, and then child and adolescent psychiatry, at U of T in 2019. This was followed by a two-year fellowship at SickKids in consultation-liaison psychiatry, neurodevelopmental assessment, and rare neurogenetic conditions associated with psychiatric and neurodevelopmental outcomes. She has also worked clinically at Holland Bloorview since 2020.
As a clinician scientist at the Bloorview Research Institute, she leads a research program focused on clinically translating genetic advances into improved mental health care in autism and neurodevelopmental disorders. Dr. Baribeau also works as a child psychiatrist at Holland Bloorview’s Child Development program’s Psychopharmacology Clinic and the Autism Communication, Learning and Behaviour program.
Links:
- Please click here to learn more about Dr. Danielle Baribeau’s education background and more.
- Danielle Baribeau, Assistant Professor, University of Toronto, Temerity Faculty of Medicine
Research Staff
- Jesiqua Rapley, Research Coordinator
- Lily He, Research Coordinator
- Christina Tsetsos, Research Assistant
Current Trainees
- Sophia Lenz, MASc Candidate
- Ajilan Sivaloganathan, Undergraduate Thesis Student
- Avery Longmore, Pediatrics Resident
Below are some of our publications.
Find more of our published work with Dr. Baribeau on Google Scholar
- Baribeau, D., Arneja, J., Wang, X., Howe, J., McLaughlin, J., Tu, K., Guan, J., Iaboni, A., Kelley, E., Ayub, M., Nicolson, R., Georgiades, R., Scherer, S., Bronskill, S., Anagnostou, E., Brooks, J. – 2023 - Short report: Linkage of whole genome sequencing and administrative health data in autism: A proof of concept study.Autism Research
- Perlman, P., Vorstman, J., Baribeau, D., Hoang, N., Summers, J., Cunningham, J., Mulsant, B. – 2023 - Support to caregivers who have received genetic information about neurodevelopmental and psychiatric vulnerability in their young children: a narrative review. Clinical Genetics.
- Kaster, T.S., Downar, J., Vila-Rodriguez, F., Baribeau, D.A., Thorpe, K.E., Daskalakis, Z.J., Blumberger, D.M. – 2023 - Differential symptom cluster responses to repetitive transcranial magnetic stimulation treatment in depression. eClinicalMedicine.
- Baribeau, D.A., Hoang, N., Selvanayagam, T, Stavropoulos, D.J., Costain, G., Scherer, S.W., Vorstman, J. - 2022 - Developmental Implications from Genetic Testing for Physical Indications. European Journal of Human Genetics
- Baribeau, D.A., Vigod, S., Pullenayegum, E., Kerns, C., Mirenda, P., Smith, I., . . . Szatmari, P. – 2022 - Developmental Cascades Between Anxiety and Insistence on Sameness Behaviour in Autism Spectrum Disorder. European Journal of Child and Adolescent Psychiatry
- Baribeau, D.A., Vigod, S., Brittain, H., Vaillancourt, T., Szatmari, P., Pullenayegum, E. – 2022 - Application of Transactional (Cross-lagged) Models in Mental Health Research: An Introduction and Review of Methodological Considerations. Journal of the Canadian Academy of Child and Adolescent Psychiatry
- Baribeau, D., Vorstman, J., Anagnostou, E. – 2022 - Novel Treatments in Autism Spectrum Disorder. Current Opinion in Psychiatry
- Baribeau, D., Anagnostou, E. – 2021 - Novel Treatments for Autism Spectrum Disorder based on Genomics and Systems Biology.Pharmacology & Therapeutics
Project: RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network
Researchers: T. Lacaze-Masmonteil (PI) and co-investigator team
Agency: Canadian Institutes of Health Research ($19,999,845, 2024-2029)
Project: Clinical Translation of a Genetic Diagnosis for Mental Health in Autism: Linking Genome Sequencing Data to Health Administrative Data
Researchers: D. Baribeau (PI) and co-investigator team
Agency: Canadian Institutes of Health Research ($366,353, 2024-2027)
Project: Predicting medication usage for autistic children using machine learning
Researchers: A. Kushki (PI) and co-investigator team
Agency: Canadian Institutes of Health Research ($75,000, 2024-2025)
Researchers: D. Baribeau (PI)
Agency: CIHR Glenda M. MacQueen Memorial Career Development Award: CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) and the Canadian Psychiatric Association (CPA) ($100,000, 2023)
Project: The AWARE Study: Efficacy of Pharmacologic Management of ADHD in Children and Youth with Autism Spectrum Disorder
Researchers: D. Coury (PI), D. Baribeau (PI: Site), and co-investigator team
Agency: Patient Centered Outcomes Research Institute and Autism Care Network Grant ($9,983,955, 2023-2027)
Project: IRIS: A Phase 2 clinical trial evaluating ML-004
Researchers: D. Baribeau (PI: Site) and co-investigator team
Agency: MapLight Therapeutics
Project: Clinical Translation of a Genetic Diagnosis for Mental Health in Autism: Linking genome sequencing and health administrative data.
Researchers: D. Baribeau (PI) and co-investigator team
Agency: McLaughlin Centre Special Research Grant ($75,000, 2023 – 2024)
Project: DNA methylation as a predictive biomarker of psychosis in 22q11.2 deletion syndrome
Researchers: R. Weksberg (PI) and co-investigator team
Agency: SickKids Garry Hurvitz Centre for Brain and Mental Health- Health Outcomes Catalyst Grant ($100,000, 2023 - 2024)
Project: The CALM Study: Child and Adolescent Multimorbidity- A Multisite Master Observational Trial
Researchers: A. Voineskos (PI), L. Gallagher (PI), and co-investigator team
Agency: Ontario Brain Institute Integrated Discovery Program ($6,000,000, 2023 - 2026)
Project: The Province of Ontario Neurodevelopmental Disorders Network
Researchers: E. Anagnostou (PI), J. Lerch (PI), and co-investigator team
Agency: Ontario Brain Institute Integrated Discovery Program ($6,200,000, 2023 - 2026)
Project: Examining the correlates of adaptive functioning in neurodevelopmental conditions: data from the Province of Ontario Neurodevelopmental Network
Researchers: A. Kushki (PI) and co-investigator team
Agency: Canadian Institutes of Health Research ($75,000, 2023 – 2024)
Project: GenEd-NDD: Education and needs assessment for pediatricians about genetic testing in neurodevelopmental disorders
Researchers: I. Peltekova (PI) and co-investigator team
Agency: Academic Health Science Centres Innovation Fund ($60,000, 2023 -2024)
Project: Implementation of wearable technology “Holly” to assess arousal during treatment in the psychopharmacology clinic
Researchers: A. Kushki (PI) and co-investigator team
Agency: Holland Bloorview SPARK Innovation Fund ($30,000, 2023 – 2024)
